Urgent

Sensitising event in pregnancy (anti-D)

Rhesus prophylaxis · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Any potentially sensitising event (bleeding, trauma, ECV, miscarriage, procedures) in a Rhesus-negative woman risks feto-maternal haemorrhage and future haemolytic disease. Timely anti-D immunoglobulin (and a Kleihauer after 20 weeks) prevents sensitisation.

Assessment

Investigations

  • Determine maternal Rhesus status
  • Identify a potentially sensitising event
  • Kleihauer test after ~20 weeks to quantify feto-maternal haemorrhage

Management

  • Give anti-D immunoglobulin to non-sensitised Rh-negative women promptly (ideally within 72 h)
  • Take a Kleihauer test after 20 weeks to guide the dose
  • Manage the underlying event (bleeding/trauma)
  • Document and arrange follow-up
  • Liaise with obstetrics/transfusion

Drugs & doses

Anti-D immunoglobulin

Disposition

Obstetrics / transfusion.

Give anti-D promptly to a Rh-negative woman after any sensitising event, and take a Kleihauer after 20 weeks to size the dose.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.